Exelixis, Inc. (EXEL)
NASDAQ·Healthcare·Biotechnology
$66.08
+1.16%
Mkt Cap $16.23B
Analyst Ratings
Buy
3
Hold
12
Sell
0
Price Target (65 analysts)
$51.78
Range $46.00 – $56.00
Implied Upside
-21.6%
Consensus $51.78 vs current $66.08
NASDAQ·Healthcare·Biotechnology
$66.08
+1.16%
Mkt Cap $16.23B
Buy
3
Hold
12
Sell
0
Price Target (65 analysts)
$51.78
Range $46.00 – $56.00
-21.6%
Consensus $51.78 vs current $66.08